![]() AKESOgen AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural | ![]() Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. | ![]() Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. | ||
Founding Date | Founding Date 2010 | Founding Date 1989 | Founding Date 1997 | Founding Date 2007 |
Type | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Norcross, US HQ | Locations Durham, US HQ | Locations Roseville, US HQ | Locations Cambridge, US HQ |
Employees | Employees 6 | Employees 3642% decrease | Employees 542% increase | Employees 324187% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.2 m | Valuation ($) N/A | Valuation ($) 359.6 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $4.9m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $236.2m (FY, 2025) |
Net income | Net income N/A | Net income ($23.4m) (FY, 2022) | Net income N/A | Net income ($5.3m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 13.8m | Total funding raised $ 5.1m | Total funding raised N/A |

Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
View company
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
View company
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View company